Emil Lou
University of Minnesota-Twin Cities
H-index: 37
North America-United States
Top articles of Emil Lou
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Genomic analysis of oesophageal carcinoma (EC) to identify recurrent mutations in histone methyltransferases as a distinctive subset. | Jingyuan Wang Joanne Xiu Matthew James Oberley Francesca Battaglin Hiroyuki Arai | 2024/1/20 | |
Identification and characterization of immunogenic neoantigens in biliary cancer (BC) and pancreatic cancer (PC). | Francesca Battaglin Andrew Elliott Joanne Xiu Sandra Algaze Jingyuan Wang | 2024/1/20 | |
Real-world analysis of insurance status and survival in patients with selected GI cancers | Cancer Research | Rebecca AbuAyed Joshua Schwanke Brooke Patterson McKenzie White Schelomo Marmor | 2024/3/22 |
Predictive value of CDC37 gene expression for targeted therapy in metastatic colorectal cancer | European Journal of Cancer | Hiroyuki Arai Yan Yang Yasmine Baca Joshua Millstein Tadamichi Denda | 2024/2/10 |
CCR5 and CCL5 gene expression in colorectal cancer: comprehensive profiling and clinical value | Journal for Immunotherapy of Cancer | Francesca Battaglin Yasmine Baca Joshua Millstein Yan Yang Joanne Xiu | 2024 |
Comprehensive molecular and immunological characterization of early-onset esophagogastric cancer | EBioMedicine | Shu Shimada Kaoru Mogushi Yoshimitsu Akiyama Takaki Furuyama Shuichi Watanabe | 2019/2/1 |
High-resolution transcriptional signature to predict survival benefit in colorectal cancer (CRC) treated with EGFR inhibitors (EGFRi) independent of RAS/BRAF mutation status or … | Ramya Thota Timothy Yeatman Nishant Gandhi Mingli Yang Michael Schell | 2024/1/20 | |
Tumor-Stroma Proportion to Predict Chemoresistance in Patients With Ovarian Cancer | JAMA Network Open | Emil Lou Valentino Clemente Marcel Grube Axel Svedbom Andrew C Nelson | 2024/2/5 |
AI enabled whole exome/transcriptome liquid biopsy addressing MCED, MRD, and therapy selection on a single platform | Liver | Jim Abraham Valeriy Domenyuk Nieves Perdigones Sergey Klimov Sourabh Antani | 2024/3/22 |
Genomics and transcriptomics of pancreatic adenosquamous carcinoma. | Brooke Elizabeth Kania Yasmine Baca Gregory Riedlinger Sanjay Goel Emil Lou | 2024/1/20 | |
LMTK3 gene expression and the molecular landscape of colorectal cancer (CRC). | Lesly Torres-Gonzalez Francesca Battaglin Shivani Soni Yasmine Baca Joanne Xiu | 2024/1/20 | |
Exploring the differences in the tumor microenvironment and immuno-oncologic targets in pancreatic ductal adenocarcinomas (PDAC) according to KRAS mutational status | ESMO Gastrointestinal Oncology | EB Faber Y Baca J Xiu P Walker G Manji | 2024/6/1 |
Molecular differences with therapeutic implications in early-onset compared to average-onset cholangiocarcinoma. | Thejus Jayakrishnan Yasmine Baca Joanne Xiu Mehrie Patel Benjamin Adam Weinberg | 2024/1/20 | |
Molecular and immune landscape by cyclin dependent kinase (CDK) 4/6 expression and TP53 mutational status in mismatch repair deficient/microsatellite instability-high (dMMR/MSI … | Alexandra Wong Nishant Gandhi Joanne Xiu Sandra Algaze Priya Jayachandran | 2024/1/20 | |
Differential responses to immune checkpoint inhibitors are governed by diverse mismatch repair gene alterations | Journal of Experimental & Clinical Cancer Research | Samantha MY Chen Vince Popolizio Rachel A Woolaver Huaibin Ge Alexandra L Krinsky | 2022/4/2 |
Differential landscape of immune evasion in oncogenic RAS-driven primary and metastatic colorectal cancers | Molecular Therapy Oncology | Emil Lou Joanne Xiu Yasmine Baca Anwaar Saeed Ajay Prakash | 2024/3/21 |
APC as a high-utility mutational biomarker that may identify subpopulations of patients with mutant RAS/BRAF and right-sided colorectal cancer (CRC) who derive … | Ramya Thota Timothy Yeatman Nishant Gandhi Mingli Yang Michael Schell | 2024/1/20 | |
Characterization of the cachexia pathway in pancreatic ductal adenocarcinoma. | Karam Ashouri Yasmine Baca Joanne Xiu Shivani Soni Pooja Mittal | 2024/1/20 | |
The genomic, transcriptomic, and immunologic landscape of TEM8 (ANTXR1) in neuroendocrine neoplasms (NENs) | Sandra Jones Harris Benjamin Krause Jose Noy Samuel A Kareff Asaad Trabolsi | 2023/6/1 | |
Tunneling nanotubes and tumor microtubes—Emerging data on their roles in intercellular communication and pathophysiology: Summary of an International FASEB Catalyst Conference … | Emil Lou Christel Vérollet Frank Winkler Chiara Zurzolo Silvana Valdebenito‐Silva | 2024/3/15 |
